Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition
Gang Wang,Qunxi Dong,Jianfeng Wu,Yi Su,Kewei Chen,Qingtang Su,Xiaofeng Zhang,Jinguang Hao,Tao Yao,Li Liu,Caiming Zhang,Richard J. Caselli,Eric M. Reiman,Yalin Wang,for the Alzheimer’s Disease Neuroimaging Initiative
DOI: https://doi.org/10.1016/j.media.2020.101877
IF: 10.9
2021-01-01
Medical Image Analysis
Abstract:<p>Cognitive decline due to Alzheimer's disease (AD) is closely associated with brain structure alterations captured by structural magnetic resonance imaging (sMRI). It supports the validity to develop sMRI-based univariate neurodegeneration biomarkers (UNB). However, existing UNB work either fails to model large group variances or does not capture AD dementia (ADD) induced changes. We propose a novel low-rank and sparse subspace decomposition method capable of stably quantifying the morphological changes induced by ADD. Specifically, we propose a numerically efficient rank minimization mechanism to extract group common structure and impose regularization constraints to encode the original 3D morphometry connectivity. Further, we generate regions-of-interest (ROI) with group difference study between common subspaces of <span class="math"><math>Aβ+</math></span>AD and <span class="math"><math>Aβ−</math></span>cognitively unimpaired (CU) groups. A univariate morphometry index (UMI) is constructed from these ROIs by summarizing individual morphological characteristics weighted by normalized difference between <span class="math"><math>Aβ+</math></span>AD and <span class="math"><math>Aβ−</math></span>CU groups. We use hippocampal surface radial distance feature to compute the UMIs and validate our work in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. With hippocampal UMIs, the estimated minimum sample sizes needed to detect a 25<span class="math"><math>%</math></span>reduction in the mean annual change with 80<span class="math"><math>%</math></span>power and two-tailed <span class="math"><math>P=0.05</math></span>are 116, 279 and 387 for the longitudinal <span class="math"><math>Aβ+</math></span>AD, <span class="math"><math>Aβ+</math></span>mild cognitive impairment (MCI) and <span class="math"><math>Aβ+</math></span>CU groups, respectively. Additionally, for MCI patients, UMIs well correlate with hazard ratio of conversion to AD (4.3, <span class="math"><math>95%</math></span>CI=<span class="math"><math>2.3−8.2</math></span>) within 18 months. Our experimental results outperform traditional hippocampal volume measures and suggest the application of UMI as a potential UNB.</p>
engineering, biomedical,computer science, interdisciplinary applications, artificial intelligence,radiology, nuclear medicine & medical imaging